Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi
Pharmaceuticals · 07.07.2026 · 19 (7) · 1046
DOI: 10.3390/ph19071046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 07.07.2026. Verfasst von Albert Ros-Lucas und 9 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, 08036 Barcelona, Spain. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a major neglected tropical disease, with millions of people living with the infection worldwide. Current treatments are effective in the acute stage of the disease, but are poorly tolerated and show reduced efficacy in chronic infections, highlighting an urgent need for novel therapeutic strategies. A key bottleneck in early-stage drug discovery is target identification, which is traditionally dependent on costly and low-throughput experimental methods. Computational approaches offer a cost-effective and fast alternative to traditional methods.
Methods
In this study, we present an integrated in silico pipeline that combines ligand-based and structure-based computational approaches to prioritize potential molecular targets for bioactive compounds against T. cruzi. The ligand-based component performed similarity searches across curated bioactivity databases containing known ligand–protein associations, and the most similar candidates were then further evaluated using a structure-based approach through pairwise structural alignment against the T. cruzi proteome from AlphaFold.
Results
The pipeline was validated using eight compounds with known targets, successfully recovering the correct target in six cases. Additionally, two compounds with anti-T. cruzi activity but unknown mechanisms of action were analyzed to hypothesize their potential targets.
Conclusions
Overall, the pipeline demonstrated moderate success, with limitations arising from challenges in handling novel chemotypes and poorly annotated targets. Nevertheless, its modular nature allows for an easy adaptation to other neglected tropical diseases, providing a flexible and cost-effective framework for early-stage target prioritization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ISGlobal, 08036 Barcelona, Spain.
- Campus Mar, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.
- Department of Clinical Microbiology, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
- Drugs for Neglected Diseases Initiative (DNDi), Rio de Janeiro 20010-020, Brazil.
ORCID-Profile: Albert Ros-Lucas, Nieves Martínez-Peinado, Juan Carlos Gabaldón-Figueira, Cristina Ballart, Montserrat Gállego, María-Jesús Pinazo, Joaquim Gascón, Ana Requena-Méndez, Julio Alonso-Padilla
Förderung
- Centro de Investigación Biomédica en Red
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Unión Europea–NextGenerationEU
- Generalitat de Catalunya
- Generalitat of Catalonia Universities and Research Department
Zitieren
APA
Ros-Lucas, A., Martínez-Peinado, N., Gabaldón-Figueira, J. C., Morillo-Osorio, M., Ballart, C., Gállego, M., Pinazo, M. J., Gascón, J., Requena-Méndez, A., & Alonso-Padilla, J. (2026). Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi. Pharmaceuticals, 19(7), 1046. https://doi.org/10.3390/ph19071046
Vancouver
Ros-Lucas A, Martínez-Peinado N, Gabaldón-Figueira JC, Morillo-Osorio M, Ballart C, Gállego M, et al. Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi. Pharmaceuticals. 2026;19(7):1046. doi:10.3390/ph19071046
BibTeX
@article{RosLucas2026,
author = {Ros-Lucas, Albert and Martínez-Peinado, Nieves and Gabaldón-Figueira, Juan Carlos and Morillo-Osorio, Maria and Ballart, Cristina and Gállego, Montserrat and Pinazo, María-Jesús and Gascón, Joaquim and Requena-Méndez, Ana and Alonso-Padilla, Julio},
title = {Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {7},
pages = {1046},
doi = {10.3390/ph19071046}
}
EUVIMED